topic: Access to Medicines
New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable
MSF reveals cost of its landmark TB clinical trial: €34 million
As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination
Namrata’s journey: triumph over drug-resistant Tuberculosis
Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis
Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests
MSF response to signing of EFTA-India trade agreement
MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions
Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is
